CZC-13788, identified by its CAS number 1035226-29-9, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. The compound is typically studied for its effects on certain biological pathways, and it may exhibit properties such as anti-inflammatory or neuroprotective effects, depending on its mechanism of action. CZC-13788 is often evaluated in preclinical studies to assess its efficacy and safety profile. As with many compounds in drug development, its solubility, stability, and pharmacokinetic properties are crucial for determining its potential as a therapeutic agent. Researchers continue to explore its interactions with biological targets, aiming to elucidate its role in disease modulation. However, detailed information regarding its specific characteristics, including its molecular weight, melting point, and solubility, would require access to specialized databases or scientific literature.

CZC-13788 is a highly potent and selective H4R antagonist. Pharmacological studies suggest the potential utility of histamine H4R antagonists/inverse agonists in the treatment of inflammatory diseases, e.g. allergic rhinitis, asthma, atopic dermatitis, colitis, or pruritus.

CZC-13788

1035226-29-9: CZC-13788, identified by its CAS number 1035226-29-9, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. The compound is typically studied for its effects on certain biological pathways, and it may exhibit properties such as anti-inflammatory or neuroprotective effects, depending on its mechanism of action. CZC-13788 is often evaluated in preclinical studies to assess its efficacy and safety profile. As with many compounds in drug development, its solubility, stability, and pharmacokinetic properties are crucial for determining its potential as a therapeutic agent. Researchers continue to explore its interactions with biological targets, aiming to elucidate its role in disease modulation. However, detailed information regarding its specific characteristics, including its molecular weight, melting point, and solubility, would require access to specialized databases or scientific literature.

<p>CZC-13788 is a highly potent and selective H4R antagonist with the potential utility in the treatment of inflammatory diseases.</p>

CAS 1035226-29-9

CZC-13788

CZC-13788

Ref: TM-T27114